Imbue Botanicals, LLC introduces transcend All Natural Pure CBD Crumble

Imbue Botanicals... For those who know...

Imbue Botanicals

transcend crumble – 1 gram

Product Facts-Crumble

Imbue Botanicals, LLC has expanded its current CBD product line with the introduction of its transcend all natural hemp CBD crumble.

PALM SPRINGS, CALIFORNIA, UNITED STATES, July 19, 2018 /EINPresswire.com/ — Palm Springs, CA, July 19, 2018 – (Press Release Point) – Imbue Botanicals, LLC, a Wyoming based company, is pleased to introduce its transcend CBD Crumble. The product addition is a further expansion of its specialty line of CBD products.

Imbue Botanicals offers an extensive line of premium CBD products produced from organically grown Colorado hemp, including CBD tinctures, vaporizer cartridges, CBD capsules and CBD topicals for both people and pets.

“We are very excited to introduce our transcend Pure CBD Crumble” said Tom Bauer, Managing Member of Imbue Botanicals. “This is something so many of our wholesale partners have asked for, and frankly, we knew we had the best crumble money could buy, so we decided to roll it out.”

Imbue’s 1 full gram of natural CBD Crumble is made solely from organic, Colorado grown CBD oil, cold processed to retain natural cannabinoids and natural terpenes. For those who desire the purest form of CBD, this is it.

Packaged in a reseal-able ¼ ounce glass jar to preserve product freshness, and see-through recyclable sleeve, the product is available online at www.imbuebotanicals.com and from select retailers.

ABOUT Imbue Botanicals, LLC:
Imbue Botanicals offers an extensive line of full spectrum, premium CBD products produced from organically grown Colorado hemp, including tinctures, capsules, topical CBD lotions and salves, and specialty products such as vaporizer cartridges. Their premium Colorado grown hemp CBD products are non GMO, cruelty free, vegan and contain no added flavorings or sugars. Available in their own online CBD store, www.imbuebotanicals.com, or through other select retailers, their products offer exceptional quality, superb packaging and unmatched value.

Imbue Botanicals offers CBD products for both people and pets. For more information, visit: www.imbuebotanicals.com
Facebook: www.facebook.com/imbuecbd
Instagram: www.instagram.com/imbuebotanicals_cbd

ABOUT Joseph Allen Agencies:
With over 40 years of combined experience, the principals at Joseph Allen specialize in design,
marketing and public relations for a diverse portfolio of clientele. At JAA, they place a significant focus on appealing to human emotion and psyche. They can handle all aspects of design and marketing needs through their internal staff, as well as through their incomparable mix of strategic partners. For more information, visit www.josephallenagencies.com

Paul Caudell
Joseph Allen Agencies, LLC
760-318-5401
email us here


Source: EIN Presswire

Intermountain Healthcare Announces Zero Suicide Initiative

SALT LAKE CITY, UTAH, USA, July 19, 2018 /EINPresswire.com/ — A new initiative, called Zero Suicide, will be helping to reduce suicide losses in Utah — which have been increasing for the past few years. Utah has one of the highest suicide rates in the nation. Several studies released recently by the Centers for Disease Control and Prevention (CDC) have shown that suicide rates have increased among all age groups.

"Last year, 45,000 people died by suicide in the United States, 630 of them in Utah," said Mark Foote, MD, senior medical director of Intermountain Healthcare Behavioral Health. "Suicide is not a new problem. The rate has gone up and down over time, but over the last 15 years, the rate has steadily gone up. This is no longer just a behavioral health problem — this is a public health crisis. We need to engage our entire system and our communities in combatting this horrible problem."

Intermountain Healthcare, the State of Utah, and numerous community groups have partnered together to find ways to reduce the deaths. Intermountain will target their suicide prevention efforts in three areas:

• Improving access to behavioral care, in part by adhering to best practices to screen, assess, and develop safety plans.
• Preparing caregivers and community organizations about how to talk about suicide and help those at risk seek help and create safety plans.
• Raising awareness about restricting access to lethal means.

Intermountain has worked for the past decade on mental health integration – bringing mental health best practices into the primary care provider’s offices. A family doctor can screen for depression, anxiety and other mental health concerns – and help get resources for their patients to be treated.

"In the future, none of us should feel at a loss for what we can do to help. As we implement the Zero Suicide framework as a part of our overall commitment to Zero Harm, we'll take a systematic approach to quality improvement that will make it easier for all of us to lead together to achieve Zero Suicide. Zero is the only acceptable number," said Mikelle Moore, Intermountain’s senior vice president of Community Health.

Intermountain Healthcare is a Utah-based not-for-profit system of 22 hospitals, 170 clinics, a Medical Group with about 2,300 employed physicians and advanced practice clinicians, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

FDA releases Biosimilar Action Plan – Hear more at this year’s Biosimilars USA conference

Biosimilars USA 2018

Following FDA’s release of Biosimilar Action Plan, this year’s Biosimilars USA conference promises to explore the developments in biosimilar drug development

LONDON, WATERLOO, UNITED KINGDOM, July 19, 2018 /EINPresswire.com/ — As the world of biosimilars gains more traction and promise, and the FDA announces the release of a long-awaited Biosimilar Action Plan, SMi’s 5th Annual Biosimilars USA Conference, taking place in New Jersey, USA on the 14th and 15th November 2018, aims to give crucial updates to biosimilar experts and scientific pioneers across the world in this rapidly evolving industry.

During a speech given this week in Washington, DC, FDA Commissioner Scott Gottlieb, MD, announced the release of the long-awaited Biosimilar Action Plan. The plan is designed to promote biosimilar competition in the US marketplace by addressing the following 4 key areas:

• Improving the efficiency of the biosimilar and interchangeable product development and approval process
• Maximizing scientific and regulatory clarity for the biosimilar product development community
• Developing effective communications to improve understanding of biosimilars among patients, providers, and payers
• Supporting market competition by reducing gaming of FDA requirements or other attempts to unfairly delay market competition to follow-on products

“While less than 2% of Americans use biologics, they represent 40% of total spending on prescription drugs,” said Gottlieb. “So, enabling a path to competition for biologics from biosimilars is a key to reducing costs and facilitating more innovation.” [centerforbiosimilars.com]

Also in recent news were statements made by the chair of this year’s two-day conference; Richard DiCicco, the chairman of Harvest Moon Pharmaceuticals USA. Richard expressed his views on Amgen, which he claims has the ability to take advantage of the unique dynamics and inefficiency of the US market as Mylan recently announced WAC for biosimilar Neulasta at $4,175/syringe and Amgen set Neulasta's WAC at $6,231, and its ASP dropped to $4,453 in the July CMS report.

According to Richard, if Mylan's biosimilar ends up as a market failure, this suggests that the US market does not allow adoption of lower-priced drugs unless the US healthcare system adapts. With both timing and pricing pressure (and Amgen is ready to protect Neulasta with bundled contracts), Richard expects Mylan to quickly move toward conversations with payers, and commercial uptake of this biosimilar will depend upon negotiation success. Richard also states that whether this biosimilar is a success or a failure has larger implications for the total success or failure of the US biosimilar market.

This year’s Biosimilars USA conference will provide delegates with the opportunity to hear from a selection of in-depth keynote addresses and case studies presented by top manufacturing and leading distributors of market-approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

The latest conference brochure, as well as other exclusive content including the full speaker line-up and an interview with expert speaker Hillel Cohen, Executive Director, Scientific Affairs, Sandoz Inc, are now available to download on the event website, where you can also register your place: www.biosimilars-usa.com/einpr

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Biosimilars USA
14th – 15th November 2018
Renaissance Woodbridge Hotel, 515 US Highway 1 South, Iselin, New Jersey, USA
www.biosimilars-usa.com/einpr

Follow us @SMiPharm
#SMiBioSimUSA

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
02078276000
email us here


Source: EIN Presswire

Just Imagine If We Had Oprah and Her Experts Pushing for Emotional Health(EH) Instead of EI!

Brain and mind are two separate entities and so mind and brain education are different.

The quality of the self-image determines the quality of life for individuals, groups and countries.

Wisdom power is emotional health power.

Emotionally Healthy Brain Generates Emotional Intelligence.

Create your pure self by healing your brain through brain education.

Stop letting your emotional baggage rule your life.

EI is the smoke where emotional health (EH) is the fire, yet our experts keep trying to create the smoke instead of lighting the fire.

Oprah & her experts must wake up to the true nature of EI. EI is a fragrance of an emotionally healthy brain and like all fragrances it cannot be created on its own. The brain has to be healed into EH”

— Sajid Khan

WASHINGTON, DC, USA, July 19, 2018 /EINPresswire.com/ — It is amazing that our experts have focused on emotional intelligence, even though it is a secondary entity. It is a fragrance of the brain, which means emotional intelligence cannot be created on its own, just like to improve the fragrance of a flower, the plant has to be improved.

We have tens of thousands of books explaining and defining emotional intelligence as an independent stand-alone entity. So our experts continue to try to teach emotional intelligence directly as if it is a subject like math or science! Emotional intelligence is a sport where it is the brain that has to be trained to generate healthy biochemicals.

Oprah and her experts continue to try to find better and better ways to teach emotional intelligence. It is like trying to find better and better ways to create smoke without lighting the fire. Just imagine how easy it will be to create smoke by lighting the fire. The fire, in this case, is emotional health (EH).

Just Imagine if we had Oprah and Her Experts Pushing for Emotional Health(EH) instead of EI!

Oprah has done immortal work in taking up emotional intelligence and helping it become center stage. However, her accomplishments will remain half-baked as long as she does not help define the true nature of emotional intelligence. Emotional intelligence springs from emotional health so her focus must shift to creating emotional health.

Look at the consequences of not figuring out the true nature of EH!

Ei is the smoke where EH is the fire. If only Oprah and our experts would focus on creating EH instead of EI, the mess in society and in education will melt away.

For decades Oprah and her experts have marketed EI and now when I am pointing out to her that she needs to correct this blunder and if she still continues to push for EI, and not push EH instead; then she leaves me no choice but to challenge her and her experts to prove me wrong.

Sajid Khan
4th R Foundation
2018141808
email us here

EI, wisdom and all emotions can now be measured. Thus making EI and wisdom into a science.


Source: EIN Presswire

Terri Mays of Tapping With Terri to be Featured on CUTV News Radio

LODI, CALIFORNIA, UNITED STATES, July 19, 2018 /EINPresswire.com/ — Modern schools are now highly pressurized environments. Administrators pressure teacher to deliver, Teachers pressure students to succeed. Add that to the now pervasive fear of school shootings and you can see why more and more students are struggling with anxiety.

Terri Mays is the founder of Tapping With Terri, where she specializes in a unique healing modality called emotional freedom technique (EFT), otherwise known as Tapping. Mays is dedicated to improving the classroom experience by teaching Tapping in schools to both students as well as teachers and administrators.

“What I have to offer is an incredible technique that is very empowering” says Mays. “Students can use it anytime they feel a little nervous, scared or angry. I am introducing a new paradigm engaging directly with the students in their classroom collectively processing their fears or anxieties.”

Tapping has its origins in helping people suffering from PTSD. Gold standard studies have proven how EFT Tapping reduces stress and anxiety. Tapping with your fingertips on acupressure points on your body lowers cortisol, allowing students to feel less anxious, more focused and more engaged.

“The students do think it’s a little weird at first, because you literally Tap on pressure point on your face and upper body but easily jump right into it,” says Mays. “Because they can immediately feel a sense of calmness after only tapping five or ten minutes they readily embrace it. We tap together using their words and it promotes a unified positive connection.”

Mays had been teaching EFT for many years as a coach when she was inspired to bring EFT into schools after recent school shootings. Mays works with students of all ages but specializes in middle and high school. She says that’s typically when students’ hope and imagination turn into believing they’re not good enough and they retreat and feel they need armor to protect themselves.

“We all tap as a class together kids really want to do well” says Mays. After tapping, students feel more confident, calmer and have improved self-esteem.”

A recent Harvard Medical School study showed kids who tapped before their exams scored up to 20 percent higher.

CUTV News Radio will feature Terri Mays in an interview with Jim Masters on July 23rd at 1pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Tapping with Terri, visit www.tappingwithterri.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Rapid Growth Follows From Clinical Research Organizations' Strategies.

LONDON, GREATER LONDON, UK, July 19, 2018 /EINPresswire.com/ — A new report from The Business Research Company, Contract Research Organizations Global Market Opportunities And Strategies To 2021 shows that the global clinical outsourcing market of services to biopharmaceutical and biotechnology companies will grow at 12% year on year up to 2021. That is an acceleration from the clinical trials market growth rate of 10% up to 2017 which raised its value to $44.4 billion. Contract research organizations (CROs) offer solutions for the conduct of clinical trials, including initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory functions, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. Their clients are the pharmaceutical and biotechnology companies.

Contract Research Organizations' Marketing Strategy
CROs' market growth is being achieved through strategies such as strategic partnerships to benefit CROs and sponsors alike, growing investments in technology and an increasing focus on emerging markets.

CROs are forming strategic partnerships with large biopharma companies to establish a strong CRO-sponsor relationship. Strategic partnerships help CROs by providing them with improved visibility, higher network utilization and expanded capabilities, while strategic deals offer sponsors attractive pricing, expertise in disease areas and regulatory compliance, improved global reach and accelerated time to market. CROs are also investing heavily in technological solutions such as wearables, whose sensor technology in wearables allows for continuous and real-time reporting of data, analytics and big data to improve the overall success of clinical trials. Incorporating these technologies into the drug development process dramatically enhances its overall efficiency through lower associated costs, reduced cycle times, improved quality of results and optimized commercialization strategies. Again, as the sponsors of the CROs struggle with the rising cost of drug/device development, they are also challenged to improve productivity and efficiency, streamline clinical trials, and meet more rigorous regulatory and quality assurance requirements in order to sustain profitability. The cost of conducting clinical trials in developing countries is around 50% less than in developed countries. Emerging regions in the CRO market are Asia Pacific, Eastern Europe and the Middle East. AS the chart shows, while Western Europe is still ahead of Asia Pacific in sales of CRO services, it is now behind it for CRO operations and production.

Download a sample of the report at:https://www.thebusinessresearchcompany.com/sample.aspx?id=791&type=smp

CRO Market Segmentation
One way of segmenting the contract research organizations' market is by the disease area of the drugs or equipment being researched. Here the segments consist of research directed at finding solutions for oncology, infectious diseases, central nervous system (CNS) disorders, cardiovascular diseases and other therapeutic areas, which include diabetes and various dermatology, respiratory and metabolic diseases.

By therapeutic area, oncology was the largest segment of the CRO market in the latest year, accounting for about 25% of the total. Part of the reason for the importance of the oncology segment is the boost to cancer drug R&D development resulting from a loosening of regulatory requirements for new cancer drugs by the US Federal Drugs Administration. The changes being implemented or considered by the FDA include allowing organ-on-chip trials to be substituted for animal trials in the early stages of the process, allowing the inclusion of non-trial data from patients, and changing the end-point benchmark from proving that the drug extends overall survival to showing that it prolongs the time a patient lives without the disease getting worse.

Segmental growth rates, however, differ from market size. For example, the metabolic disease segment, which researches for treatments for diabetes and glandular disorders, is growing faster than the oncology segment. This is mainly due to demand for CRO services for new drug development through academia-industry collaborations.

Where To Learn More
Read the Contract Research Organizations Global Market Opportunities And Strategies To 2021 from The Business Research Company for information on the following:

Markets Covered: Contract research organizations
Contract Research Organizations Market Companies Covered: IQVIA, Laboratory Corporation Of America Holdings, ICON Plc, PAREXEL International Corporation, Pharmaceutical Product Development (PPD), Inc.
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data Segmentations: CRO market historic and forecast size and growth rates for the world, 7 regions and 12 countries, CRO market segmentation by service type (drug discovery, phase III, phase II, preclinical studies, phase IV, phase I, others), and by therapeutic area (oncology, CNS disorder, cardiovascular disease, metabolic disease, infectious disease, other therapeutic area), segment shares, and growth rates for the world, 7 regions and 12 countries, global competitor sales and market shares.
Other Data: Per capita average CRO expenditure, by country, CRO market size as a percentage of GDP across countries
Other Information: Drivers and restraints of the global CRO market, company profiles including products, strategy and financial performance for 5 CRO companies, CRO market trends and strategies, CRO market key mergers and acquisitions, global and by country
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Number of Figures in the report: 171
Number of Tables in the report: 171

Download Complete Table of Contents at:https://www.thebusinessresearchcompany.com/sample.aspx?id=791&type=toc

Interested to know more? Here is a list of reports similar to “Contract Research Organizations Global Market Opportunities And Strategies To 2021”:

Medical Equipment Global Market Report 2018
Medical And Diagnostic Laboratory Services Global Market Report 2018
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021
Pharmaceutical Drugs and Biologics Logistics Global Market Opportunities And Strategies To 2021

About The Business Research Company
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here


Source: EIN Presswire

The SafeCare Group Granted Trademark for “Recognizing Healthcare Excellence”

Recognizing Healthcare Excellence®

100 SafeCare Hospitals®

Fifth Annual Hospital Ratings

Since 2013, 100 SafeCare Hospitals has emerged as a leader in Recognizing Healthcare Excellence

When a hospital attains 100 SafeCare Hospitals, it has demonstrated superior performance in metrics that matter to patients, caregivers, and payers alike”

— Yisrael Safeek, MD, MBA, CEO, The SafeCare Group

LEXINGTON, KENTUCKY, USA, July 19, 2018 /EINPresswire.com/ — The SafeCare Group® successfully protected its intellectual property rights by formally applying for and receiving Registered Trademark Status for its 100 SafeCare Hospitals® as Recognizing Healthcare Excellence®.

The 100 SafeCare Hospitals® brand has become synonymous for Recognizing Healthcare Excellence® from its holistic, evidence-based metrics that reflect a balanced scorecard of healthcare excellence. Recognizing Healthcare Excellence® refer to 100 SafeCare Hospitals that excel in evidence-based metrics of low infections, low complications, low readmissions, high patient satisfaction, and high value of care. The top 50 hospitals represent the top 1% performance in the evidence-based metrics of HVBP, HACRP, and HRRP, and only about 2% percent of US hospitals earn the prestigious 100 SafeCare Hospitals® distinction.

Yisrael Safeek, MD, MBA, CEO of The SafeCare Group, commented on the recent registered trademark status. “Since 2013, 100 SafeCare Hospitals has emerged as a leader in recognizing healthcare excellence.” Dr. Safeek continued, “When a hospital attains 100 SafeCare Hospitals, it has demonstrated superior performance in metrics that matter to patients, caregivers, and payers alike. We felt our company’s hard-earned reputation was something worth protecting and wanted to prevent any confusion in the marketplace. To help protect the value of the designation in the marketplace, The SafeCare Group applied for and recently received registered trademark status for Recognizing Healthcare Excellence by the US Patent and Trademark Office (USPTO).”
Over the last five years, 100 SafeCare Hospitals® has celebrated impressive accomplishments:
• November 2013 – Released first listing
• December 2014 – Added ranking to our listings
• December 2015 – Offered 38 page QAPI Report to our services
• December 2015 – Offered press coverage in SafeCare magazine
• December 2017 – To commemorate 100 SafeCare Hospitals 5th anniversary, The SafeCare Group has released a celebratory logo to be used in conjunction with the standard product badge.
• January 2018 – Release fifth annual listing with rankings.

About The SafeCare Group
The SafeCare Group was founded in 2010 and its motto is “Innovating, Disrupting, Transforming” healthcare. The SafeCare Group SaaS solutions known as SafeCareSoft® enable hospitals to take advantage of disruptive healthcare software that optimize hospital reimbursement and accreditation. Since 2012, SafeCare Analytics® have been helping hospitals excel with physician privileging software for Joint Commission OPPE, and hospital software for better readmissions, complications, infections, and value. Since 2013, 100 SafeCare Hospitals® listings have been Recognizing Healthcare Excellence® of 100 US hospitals that excelled with low infections, readmissions, and complications. Since 2015, SafeCare® magazine has been delivering information on the people, ideas and novel technologies affecting access, cost, and quality of healthcare across the globe.

For more information about The SafeCare Group’s trademarks, visit
https://www.safecaregroup.com/the-safecare-group-trademarks.html

Sarju Bharucha, JD
SafeCare Magazine
800-700-9481
email us here

100 SafeCare Hospitals Methodology


Source: EIN Presswire

CCP adds Homestyle to its aged care foothold

LPLAN – Sigfox, NB-IoT and LTE Cat M1

CCP Protects Perishable Food

Aged care embraces IoT to strengthen food safety and reduce costs

CCP Technologies Limited (ASX:CT1) (ASX:CT1)

ST KILDA, VICTORIA, AUSTRALIA, July 19, 2018 /EINPresswire.com/ — Homestyle Aged Care Services is implementing the CCP Solution across ten residential care homes in the greater Melbourne metropolitan and Geelong areas.

In aged care settings, elderly people are more vulnerable to food safety risks which can have serious consequences. According to the Australian Institute of Food Safety, people’s immune systems tend to grow weaker as they grow older. To underpin food safety, potentially hazardous foods must be kept under temperature control conditions and temperature records must be kept.

Tim Humphries, Chief Executive Officer of Homestyle Aged Care said,

“We are using CCP’s Internet of Things (IoT) solution to deliver an immediate benefit to our food service operations. By implementing this solution, continuous temperature monitoring of refrigeration in our kitchen strengthens food safety straightaway. We’ll also take advantage of built-in analytics to ensure our fridges are performing optimally. This will improve food shelf-life, reduce food waste and support energy efficiency.”

Based on CCP data, 4.9% of refrigerated coolers and freezers in businesses will suffer a complete failure each year. If fridges breakdown in an aged care food service operation, it causes enormous business disruption and can put people’s lives at risk.

CCP continues to build a foothold in the growing Aged Care sector. According to the Australian Institute of Health and Welfare, there were 902 organisations providing residential aged care through 2,672 services at 30 June 2017. In addition, there were 1,523 organisations funded to provide home support over 2016/17 through 3,308 services. Substantial food service operations exist to support residential aged care facilities and home support services. CCP estimates the food service temperature monitoring market for the Aged Care sector in Australia to be over 50,000 monitoring points.

According the Clean Energy Corporation Australia, health and aged care facilities are among the most energy-intensive in Australia. Customers in these sectors are set to benefit from the introduction of CCP’s new appliance-level energy monitoring solution.


About CCP Network
CCP Technologies Limited – a listed public company on the Australian Securities Exchange – offers a critical control point management system in Australia and North America, and has an emerging presence in Singapore. Critical control points are the points in a supply chain where a failure of standard operating procedure has potential to cause serious harm to people – and to a business’ reputation and bottom line. Standard critical control points include temperature, energy, environment (e.g. air and water quality, pH, chemicals, noise, acoustics and gases) and movement.
CCP captures data using Smart Tags (sensors) and an advanced Internet of Things (IoT) solution which leverages WiFi and various Low-Power Wide-Area Network (LPWAN) connectivity options, including NB-IoT and LTE Cat-M1 and Sigfox networks. Data is delivered to the company’s big data cloud platform where it is analysed to deliver business intelligence. Customers access this information through Web and Mobile Dashboards; and receive real-time alerts via SMS, email and push notifications.
The company has recently announced its hand-held temperature probes, power monitoring Smart Tags, shipment monitoring and various other solutions to support businesses with food service operations.
For further information on the CCP Solution, visit: www.ccp-network.com

Further information:
Michael White | Executive Director & CEO
CCP Technologies Limited
E: michael.white@ccp-network.com
W: www.ccp-network.com
M: +61 (0) 412 799 232
Investor relations: www.ccp-technologies.com

Michael White | Executive Director & CEO
CCP Technologies
+61 (0) 412 799 232
email us here


Source: EIN Presswire

Knight Bridge Investment Consultants Limited – Strong Earning Push S&P500 to 5 Month Highs

Earnings Season Starts Positively – S&P500 @ 5mth Highs

The S&P 500 rose to its highest in more than five months and the Dow climbed for a fifth session on Wednesday as solid earnings boosted stocks.

HONG KONG, HONG KONG, HONG KONG, July 19, 2018 /EINPresswire.com/ — Knight Bridge’s purpose is to provide access to alternative investment strategies for clients seeking to achieve a diverse and profitable portfolio. Today’s asset allocation landscape is more than just equities and bonds. Our goal is to keep our clients fully informed as to the different alternatives available in today’s climate, maximizing returns and allocating investment products for long-term results that support clients’ retention for their investment cycle.

Major News and Moves

Amazon briefly tops $900 bln in market cap
Morgan Stanley jumps on earnings beat
UAL, CSX results boost transportation stocks
Dow up 0.32 pct, S&P up 0.22 pct, Nasdaq down 0.01 pct

The S&P 500 rose to its highest in more than five months and the Dow climbed for a fifth session on Wednesday as solid earnings boosted financial and industrial stocks and reinforced expectations for a strong second-quarter reporting season.

Upbeat earnings from railroad CSX Corp and airline United Continental helped lift the S&P 500 industrials index, which gained 1.1 percent and was among the day’s best-performing sectors.

Both the Healthcare and the Energy sectors saw gains, both adding close to 5% for July so far making them sectors to keep an eye on.

The Dow Jones Transport Average jumped 2.3 percent, its biggest daily advance in three months.
Although it is still early in the reporting period, estimates for the U.S. earnings season are improving as more companies release results.

S&P 500 earnings are now expected to have increased 21.4 percent in the second quarter, up from an estimate of 20.7 percent on July 1. Of the 48 companies in the index that have reported so far, 87.5 percent posted earnings above analyst expectations.

“We’ve been having this very nice rally,” said Jim Anderson, chief market analyst at Knight Bridge Investment Consultants in Hong Kong. “The reason for that is earnings and valuations.”

“I think the market would be a lot higher right now if it wasn’t for people worried about trade,” Anderson said.

Federal Reserve Chairman Jerome Powell, questioned by members of a House of Representatives committee, repeated on Wednesday that rising world protectionism would over time pose a risk to a U.S. and global expansion that appears largely on track to continue.

The Dow Jones Industrial Average rose 79.4 points, or 0.32 percent, to 25,199.29, the S&P 500 gained 6.07 points, or 0.22 percent, to 2,815.62 and the Nasdaq Composite dropped 0.67 point, or 0.01 percent, to 7,854.44.

Data showed the U.S. housing market continues to be an economic soft spot. Housing starts fell 12.3 percent in June to a nine-month low as homebuilders struggled with higher lumber prices and persistent land and labor shortages.

Amazon.com’s stock market value briefly reached $900 billion for the first time, marking a major milestone in its 21-year trajectory as a publicly listed company and threatening to dislodge Apple as Wall Street’s most valuable jewel.

Berkshire Hathaway led the financial sector higher, rising 5.3 percent on news that the company eliminated a restriction on its ability to buy back its own stock.

Morgan Stanley shares rose 2.8 percent after the investment bank reported better-than-expected quarterly profit.

Shares of Google parent Alphabet edged lower after EU antitrust regulators hit the tech company with a record $5 billion fine.

Advancing issues outnumbered declining ones on the NYSE by a 1.21-to-1 ratio; on Nasdaq, a 1.18-to-1 ratio favored advancers.

The S&P 500 posted 30 new 52-week highs and no new lows; the Nasdaq Composite recorded 102 new highs and 47 new lows.

Volume on U.S. exchanges was 6.0 billion shares, compared to the 6.48 billion average over the last 20 trading days.

Even with all of the concerns over potential trade issues between the US, China and Europe, we are still seeing positive economic data coming from these three regions, to find out more about where Knight Bridge Investment Consultants Limited sees value, both domestically and internationally, visit www.knightbridgeinvestment.com or contact us at info@knightbridgeinvestment.com for further information.

Charles Wi
Knight Bridge Investment Consultants Limited
+85258086039
email us here


Source: EIN Presswire

New York Corporate Whistleblower Center Now Urges an Analyst or Broker with Proof A Bank or Real Estate Developer Is Lying About Profitability to Inflate the Stock Price to Call About Whistleblower Rewards

Call us at 866-714-6466 if you can prove senior management at a publicly traded company is lying to shareholders about profitability or liabilities.”

— New York Corporate Whistleblower Center

WASHINGTON, DC, USA, July 19, 2018 /EINPresswire.com/ — According to the New York Corporate Whistleblower Center, "If you are an employee of a publicly traded bank, mortgage lending company, a real estate developer or a stock broker analyst who watches a company-institution like this very closely-please call us anytime at 866-714-6466 if you can prove senior management is lying about profitability or liabilities. The whistleblower rewards for this type of information can be in the millions of dollars and frequently the whistleblower remains anonymous-his/her name is not disclosed." http://NewYork.CorporateWhistleblower.Com

The Corporate Whistleblower Center would like to hear from mortgage, banking or real estate developer employees or insiders with proof of the following:

* A shopping center or multi-family apartment REIT CEO who is lying to shareholders about profits or long-term outlook.
* A bank CEO who is lying to their customers about mortgage fees, and or the buyer receiving the 'best possible interest rates' or title insurance costs or related fees.
* Bank senior management that is gouging bank mortgage borrowers on interest rates, mortgage fees, and associated products such as title insurance where the bank is receiving an illegal kickback.
* A publicly traded home builder that knowingly hires subcontractors that pay no taxes on their employees because-the employees are illegal aliens.
* A national title insurance company that is paying bribes or kickbacks to various real estate brokers nationwide so the brokers will force their clients into using an overpriced title insurance policy.

The New York Corporate Whistleblower Center says, "If you work as a manager for a bank, mortgage lender a real estate developer or a regional or national home builder or you are a stock broker analyst who has proof a company is lying to shareholders about profitability or liabilities please give us a call at 866-714-6466 and let's have a confidential chat about the SEC whistleblower program. This program is all about keeping publicly traded companies honest with their shareholders. Please don't sit on a potentially winning lotto ticket without ever knowing what it might have been worth." http://NewYork.CorporateWhistleblower.Com

Simple rules for a whistleblower from the Corporate Whistleblower Center: Do not go to the government first if you are a potential whistleblower with substantial proof of wrongdoing. The Corporate Whistleblower Center says, “Major whistleblowers frequently go to the government thinking they will help. It’s a huge mistake. Do not go to the news media with your whistleblower information. Public revelation of a whistleblower’s information could destroy any prospect for a reward. Do not try to force a company/employer or individual to come clean about significant lying to their shareholders, Medicare fraud, overbilling the federal government for services never rendered, multi-million-dollar state or federal tax evasion, or a New York based company falsely claiming to be a minority owned business to get preferential treatment on federal or state projects. Come to us first, tell us what type of information you have, and if we think it’s sufficient, we will help you with a focus on you getting rewarded.” http://CorporateWhistleblower.Com

Unlike any group in the US the Corporate Whistleblower Center can assist a potential whistleblower with packaging or building out their information to potentially increase the reward potential. They will also provide the whistleblower with access to some of the most skilled whistleblower attorneys in the nation. For more information a possible whistleblower with substantial proof of wrongdoing anywhere in New York State can contact the Whistleblower Center at 866-714-6466 or contact them via their website at http://NewYork.CorporateWhistleBlower.Com.

For information about a recent SEC whistleblower reward please refer to a July 2017 Securities and Exchange Commission press release on this topic: https://www.sec.gov/news/press-release/2017-134

Thomas Martin
New York Corporate Whistleblower Center
866-714-6466
email us here


Source: EIN Presswire